# INMUNE BIO INC (INMB)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/INMB/

- Reporting holders: 2
- Reported value: $22.4K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Bill Few Associates, Inc.](https://holderbook.com/funds/1914644-bill-few-associates-inc/) | $20.8K | 10,675 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $1.6K | 829 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $22.4K |
| Q2 2026 | 83 | $7.6M |
| Q1 2026 | 82 | $6.2M |
| Q4 2025 | 76 | $8.2M |
| Q3 2025 | 74 | $11.9M |
| Q2 2025 | 92 | $27.5M |
| Q1 2025 | 82 | $52.7M |
| Q4 2024 | 75 | $31.7M |
| Q3 2024 | 69 | $31.2M |
| Q2 2024 | 58 | $41.6M |
| Q1 2024 | 53 | $33.5M |
| Q4 2023 | 48 | $27.0M |